As of January 2026 Adaptimmune Therapeutics has a market cap of โน1.31 Billion. This makes Adaptimmune Therapeutics the world's 10242th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.